Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Dec 20, 2024, 4:00 PM
1.020
+0.020 (2.00%)
After-hours: Dec 20, 2024, 6:37 PM EST

Immunic Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
77
Market Cap
90.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FONAR 102.01M
Harvard Bioscience 97.73M
Journey Medical 57.77M
electroCore 23.33M
Veru Inc. 16.89M
Adverum Biotechnologies 1.00M
Avalo Therapeutics 820.00K
Zentek 29.13K
Revenue Rankings